Skip to main content

Table 3 Descriptive statistics of NA distribution in AZ inhouse and ChEMBL data sets

From: Nonadditivity in public and inhouse data: implications for drug design

 

Observations

Mean

Variance

Std

Skewness

Kurtosis

AstraZeneca

3,053,055

0

0.42

0.65

0

3.13

ChEMBL

1,246,975

0

0.46

0.68

0.01

4.52

  1. Note that all NA values have not been converted to absolute values prior to these calculations